Skip to main content
TipRanks
Go Ultimate75% OFF

Hikma Pharmaceuticals (HKMPY) Income Statement

43 Followers

Hikma Pharmaceuticals Income Statement

Last quarter (Q2 2026), Hikma Pharmaceuticals's total revenue was $1.73B, an increase of 10.11% from the same quarter last year. In Q2, Hikma Pharmaceuticals's net income was $222.96M. See Hikma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 3.36B$ 3.13B$ 2.88B$ 2.52B$ 2.55B
$ 1.44B$ 1.42B$ 1.41B$ 1.24B$ 1.30B
$ 808.00M$ 803.00M$ 1.04B$ 956.00M$ 719.00M
Depreciation and Amortization$ 212.50M$ 197.00M$ 198.00M$ 193.00M$ 144.00M
$ 781.82M$ 727.00M$ 566.00M$ 691.00M$ 743.00M
$ 569.33M$ 612.00M$ 367.00M$ 282.00M$ 582.00M
$ -49.11M$ -158.00M$ -86.00M$ -49.00M$ -39.00M
$ 520.21M$ 454.00M$ 281.00M$ 233.00M$ 543.00M
$ 402.94M$ 359.00M$ 190.00M$ 188.00M$ 421.00M
Per Share Metrics
Basic EPS$ 3.66$ 3.24$ 1.70$ 1.68$ 3.64
Diluted EPS$ 3.62$ 3.22$ 1.72$ 1.68$ 3.62
Weighted Average Shares Outstanding110.29M110.67M111.18M111.86M115.50M
Weighted Average Shares Outstanding (Diluted)111.34M111.75M111.18M112.50M116.50M

Currency in USD

Hikma Pharmaceuticals Earnings and Revenue History

-2B02B4B-60 %-30 %0 %30 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin